Our results, therefore, indicate that combining SAC inhibition with tubulin deregulation is synergistically toxic to cells and might provide a powerful means to target cancer cells with a CIN phenotype. The gene discussed is ADCY10; the disease is cervical squamous intraepithelial neoplasia.